Snowball logo
logo
VOGX

Vogenx Inc Common Stock

VOGX • NASDAQ
$17.34-$0.11  (0.63%)
Estimate
EPS
-0.12
Beta
-0.001
Forecast
EPS (FWD)
-1.52
About the company
Ticker
VOGX
ISIN
Country
United States of America
Sector (GICS)
Other
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

Frequently asked questions

What sector does Vogenx Inc Common Stock (VOGX) operate in?

Vogenx Inc Common Stock belongs to the Other sector and operates in the Biotechnology industry.

What is Vogenx Inc Common Stock (VOGX) current stock price?

As of the latest data, Vogenx Inc Common Stock stock price is $17.34, with a previous close of $17.45. Vogenx Inc Common Stock lost -$0.11 in the last trading session, representing a -0.63% loss.

What is Vogenx Inc Common Stock (VOGX) current market capitalization?

Vogenx Inc Common Stock market cap is approximately 257.59 million.

What is Vogenx Inc Common Stock (VOGX) Earnings Per Share (EPS)?

The trailing EPS is -$0.12, and the forward EPS is -$1.52.

Does Vogenx Inc Common Stock (VOGX) pay dividends?

No. Vogenx Inc Common Stock does not pay a dividend.

What is Vogenx Inc Common Stock (VOGX) beta (volatility) score?

Vogenx Inc Common Stock has a beta of -0.001, indicating lower volatility than the overall market.